Fruth Investment Management Abb Vie Inc. Transaction History

Fruth Investment Management

$385 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $39,955 - $45,525	-250 Reduced 2.84%	8,551 $1.56 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $65,360 - $73,610	-475 Reduced 5.12%	8,801 $1.36 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $66,795 - $77,325	-500 Reduced 5.11%	9,276 $1.38 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $51,148 - $63,651	-386 Reduced 3.8%	9,776 $1.32 Million
Q1 2023 Apr 26, 2023	SELL	$144.61 - $166.54 $107,300 - $123,572	-742 Reduced 6.8%	10,162 $1.62 Million
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $1.2 Million - $1.44 Million	-8,698 Reduced 44.37%	10,904 $1.76 Million
Q3 2022 Oct 13, 2022	SELL	$134.21 - $153.93 $728,089 - $835,070	-5,425 Reduced 21.68%	19,602 $2.63 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $483,734 - $614,984	-3,515 Reduced 12.32%	25,027 $4.1 Million
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $6,598 - $8,187	-50 Reduced 0.17%	28,542 $4.63 Million
Q4 2021 Jan 14, 2022	SELL	$107.43 - $135.93 $38,137 - $48,255	-355 Reduced 1.23%	28,592 $3.87 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $3,192 - $3,623	-30 Reduced 0.1%	28,947 $3.12 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $77,329 - $86,149	-735 Reduced 2.47%	28,977 $3.26 Million
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $46,281 - $62,485	-575 Reduced 1.9%	29,712 $3.18 Million
Q3 2020 Oct 07, 2020	SELL	$85.91 - $100.83 $64,432 - $75,622	-750 Reduced 2.42%	30,287 $2.65 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $35,657 - $47,715	486 Added 1.59%	31,037 $3.05 Million
Q4 2019 Jan 10, 2020	SELL	$72.13 - $90.25 $26,255 - $32,851	-364 Reduced 1.18%	30,551 $2.7 Million
Q3 2019 Oct 09, 2019	SELL	$62.98 - $75.72 $9,447 - $11,358	-150 Reduced 0.48%	30,915 $2.34 Million
Q2 2019 Jul 15, 2019	SELL	$65.7 - $83.98 $21,352 - $27,293	-325 Reduced 1.04%	31,065 $2.26 Million
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $238,362 - $280,541	-3,090 Reduced 8.96%	31,390 $2.53 Million
Q4 2018 Jan 16, 2019	SELL	$77.85 - $96.01 $54,494 - $67,207	-700 Reduced 1.99%	34,480 $3.18 Million
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $8,891 - $9,884	-100 Reduced 0.28%	35,180 $3.33 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $99,830 - $133,682	-1,085 Reduced 2.98%	35,280 $3.34 Million
Q4 2017 Jan 09, 2018	SELL	$89.56 - $98.21 $34,032 - $37,319	-380 Reduced 1.03%	36,365 $3.52 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $2.57 Million - $3.28 Million	36,745	36,745 $3.27 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fruth Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Fruth Investment Management with notifications on news.

Account